Advanced search
Publication Cover
Scandinavian Journal of Infectious Diseases Volume 39, 2007 - Issue 9
Submit an article Journal homepage
117
Views
6
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Comparison of two oral regimens for the outpatient treatment of low-risk cancer patients with chemotherapy-induced neutropenia and fever: Ciprofloxacin plus cefuroxime axetil versus ciprofloxacin plus amoxicillin/clavulanate

Nikolaos V. Sipsas From the Pathophysiology Department, Laikon General Hospital and Medical School, National and Kapodistrian University of Athens, Athens, GreeceCorrespondence[email protected]
,
Christos Kosmas Second Division of Medical Oncology, Department of Medicine, ‘Metaxa’ Cancer Hospital, Piraeus, Greece
,
Panayiotis D. Ziakas From the Pathophysiology Department, Laikon General Hospital and Medical School, National and Kapodistrian University of Athens, Athens, Greece
,
Athanasios Karabelis Second Division of Medical Oncology, Department of Medicine, ‘Metaxa’ Cancer Hospital, Piraeus, Greece
,
Maria Vadiaka From the Pathophysiology Department, Laikon General Hospital and Medical School, National and Kapodistrian University of Athens, Athens, Greece
,
Elias Skopelitis From the Pathophysiology Department, Laikon General Hospital and Medical School, National and Kapodistrian University of Athens, Athens, Greece
,
Theodore Kordossis From the Pathophysiology Department, Laikon General Hospital and Medical School, National and Kapodistrian University of Athens, Athens, Greece
&
Nikolaos Tsavaris From the Pathophysiology Department, Laikon General Hospital and Medical School, National and Kapodistrian University of Athens, Athens, Greece
 show all
Pages 786-791 | Received 24 Nov 2006, Published online: 08 Jul 2009

References

  • Sickles EA, Greene WH, Wiernik PH. Clinical presentation of infection in granulopenic patients. Arch Intern Med 1975; 135: 715–9
  • Sipsas NV, Bodey GP, Kontoyiannis DP. Perspectives for the management of febrile neutropenic patients with cancer in the 21st century. Cancer 2005; 103: 1103–13
  • Talcott JA, Finberg R, Mayer RJ, Goldman L. The medical course of cancer patients with fever and neutropenia. Clinical identification of a low risk subgroup at presentation. Arch Intern Med 1988; 148: 2561–8
  • Klastersky J, Paesmans M, Rubenstein EB, Boyer M, Elting L, Feld R, et al. The multinational association for supportive care in cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol 2000; 18: 3038–51
  • Rolston KVI. New trends in patient management: risk-based therapy for febrile patients with neutropenia. Clin Infect Dis 1999; 29: 515–21
  • Kern WV. Risk assessment and treatment of low-risk patients with febrile neutropenia. Clin Infect Dis 2006; 42: 533–40
  • Vidal L, Paul M, Ben DI, Soares-Weiser K, Leibovici L. Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients: a systematic review and meta-analysis of randomized trials. J Antimicrob Chemother 2004; 54: 29–37
  • Scott LJ, Ormrod D, Goa KL. Cefuroxime axetil: an updated review of its use in the management of bacterial infections. Drugs 2001; 61: 1455–500
  • Freifeld A, Marchigiani D, Walsh T, Chanock S, Lewis L, Hiemenz J, et al. A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy. N Engl J Med 1999; 341: 305–11
  • Kern WV, Cometta A, De Bock R, Langenaeken J, Paesmans M, Gaya H. Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy. N Engl J Med 1999; 341: 312–8
  • Finberg RW, Talcott JA. Fever and neutropenia: how to use a new treatment strategy. N Engl J Med 1999; 341: 362–3
  • Talcott JA, Whalen A, Clark J, Rieker PP, Finberg R. Home antibiotic therapy for low-risk cancer patients with fever and neutropenia: a pilot study of 30 patients based on a validated prediction rule. J Clin Oncol 1994; 12: 107–14
  • Rubenstein EB, Rolston K, Benjamin RS, Loewy J, Escalante C, Manzullo R, et al. Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer. Cancer 1993; 71: 3640–6
  • Malik IA, Khan WA, Karim M, Aziz Z, Khan MA. Feasibility of outpatient management of fever in cancer patients with low-risk neutropenia: results of a prospective randomized trial. Am J Med 1995; 98: 224–31
  • The EORTC International Antimicrobial Therapy Project group. Three antibiotic regimens in the treatment of infection in febrile granulopenic patients with cancer. J Infect Dis 1978;137:14–29.
  • Bodey GP, Rolston KVI. Management of fever in neutropenic patients. J Infect Chemother 2001; 7: 1–9
  • Klastersky J. Concept of empirical therapy with antibiotic combinations: indications and limits. Am J Med 1986; 80: 2–12
  • Wisplinghoff H, Seifert H, Wenzel RP, Edmond MB. Current trends in epidemiology of nosocomial bloodstream infections in patients with haematological malignancies and solid neoplasms in hospitals in the United States. Clin Infect Dis 2003; 36: 1103–10
  • Girmenia C, Russo E, Carmosino I, Breccia M, Dragoni F, Latagliata R, et al. Early hospital discharge with oral antimicrobial therapy in patients with haematological malignancies and low-risk febrile neutropenia. Ann Hematol 2007; 86: 263–70
  • Bodey GP, Buckley M, Sathe YS, Freireich EJ. Quantitative relationships between circulating leukocytes and infection in patients with acute leukaemia. Ann Intern Med 1966; 64: 328–40
  • Chamilos G, Bamias A, Efstathiou E, Zorzou PM, Kastritis E, Kostis E, et al. Outpatient treatment of low-risk neutropenic fever in cancer patients using oral moxifloxacin. Cancer 2005; 103: 2629–35
  • Claxton AJ, Cramer J, Pierce C. Impact of dose frequency upon adherence. Analysis of 76 studies of electronic monitoring of adherence. Clin Ther 2001; 23: 1296–1310

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.